2 completed, 2 recruiting, 2 unknown. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Not applicable | 1 | Recruiting 1 |
Follow Hematopoietic System--Cancer: new trials by email Literature Review of Hematopoietic System--Cancer trials Research Report on Hematopoietic System--Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment 29-XeMRI imaging - Pulmonary, Pneumonia | Recruiting | M.D. Anderson Cancer Center | 25 | 2024-08-14 | 2026-08-25 | |
| Exercise and Health Counseling in Pediatric Hematopoietic Stem Cell Transplantation Control Group (Active Comparator), Intervention Group - Hematopoietic System--Cancer | Not applicable | Recruiting | Alejandro Lucia | 48 | 2024-04-01 | 2026-08-24 |
| Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients Cancer, Hematopoietic System--Cancer | Completed | St. Jude Children's Research Hospital | 21 | 2022-06-29 | 2026-04-15 | |
| RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy Olanzapine, Placebo Oral Tablet - Vomiting in Infants and/or Children, Nausea | Phase 2 | Completed | The Hospital for Sick Children | 161 | 2017-08-10 | 2026-09-25 |
| Modified Post-Transplant Cyclophosphamide Regimen for Children With Juvenile Myelomonocytic Leukemia Decitabine - Hematopoietic System--Cancer | Unknown | Capital Research Institute of Pediatrics | 6 | 2015-04-10 | 2018-10-02 | |
| Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML Cyclophosphamide - Hematopoietic System--Cancer | Phase 2 | Unknown | Capital Research Institute of Pediatrics | 100 | 2015-03-01 | 2018-08-31 |
Neoplasms (3) · Hematologic Neoplasms (1) · Motor Activity (1) · Nausea (1) · Pneumonia (1) · Vomiting (1)
Behavior (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Infections (1) · Lung Diseases (1) · Neoplasms by Site (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
Control Groups (1) · Cyclophosphamide (1) · Decitabine (1) · Exercise (1) · Olanzapine (1)
Capital Research Institute of Pediatrics (2) · Alejandro Lucia (1) · M.D. Anderson Cancer Center (1) · St. Jude Children's Research Hospital (1) · The Hospital for Sick Children (1)
United States (3) · Canada (1) · China (1) · India (1) · Spain (1)
Ajay Sheshadri (1) · Diego Hijano, MD (1) · Jia Y Qin, MD (1) · Lee Dupuis, RPh, PhD (1) · Muhammad Ali, MD (1)
PMID 25564399, PMID 29129488, PMID 29396905, PMID 29528181, PMID 30009980, PMID 30041010, PMID 30087460